Related Experiment Video
Updated: Jul 16, 2026

08:04
Pancreatic Tissue Dissection to Isolate Viable Single Cells
Published on: May 26, 2023
Gene expression patterns in pancreatic tumors, cells and tissues
Anson W Lowe1, Mari Olsen, Ying Hao
1Department of Medicine, Stanford University Medical Center, Stanford, California, United States of America. lowe@stanford.edu
Plos One
|March 29, 2007
Summary
This study analyzed gene expression in pancreatic tumors and normal tissues. Findings reveal unique profiles for different tumor types and suggest the pancreatic duct as the origin of adenocarcinomas, aiding in diagnostic and therapeutic development.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Pancreatic cancers, originating from endocrine and exocrine cells, are a leading cause of cancer mortality.
- Comprehensive gene expression analysis is crucial for understanding pancreatic tumorigenesis and developing targeted therapies.
Purpose of the Study:
- To comprehensively assess and compare gene expression profiles across various pancreatic tumors, normal pancreatic tissues, and nonneoplastic diseases.
- To identify potential diagnostic markers and therapeutic targets for pancreatic cancer based on distinct gene expression patterns.
Main Methods:
- Utilized DNA microarrays to analyze gene expression in surgically resected pancreatic adenocarcinomas, islet cell tumors, and mesenchymal tumors.
- Integrated data from normal pancreata, isolated islets, pancreatic ducts, and pancreatic adenocarcinoma cell lines to broaden the scope of gene expression analysis.
Main Results:
- Exocrine, endocrine, and mesenchymal pancreatic tumors exhibited distinct gene expression profiles.
- Gene expression similarities between adenocarcinomas and pancreatic ducts support the ductal origin of these tumors.
- Identified genes highly expressed in other cancers and linked to specific signal transduction pathways within pancreatic tumors.
Conclusions:
- Inclusion of diverse public datasets enhanced the identification of candidate genes for pancreatic cancer.
- Identified candidate genes hold potential for future diagnostic and therapeutic applications in managing pancreatic cancer.

